EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Systemic and local complement activation in peritoneal dialysis patients via conceivably distinct pathways

Bernardo Faria, Mariana Gaya da Costa, Anita H Meter-Arkema, Stefan P Berger, Carla Lima, Catia Pêgo, Jacob van den Born, Casper Fm Franssen, Mohamed R Daha, Manuel Pestana, Marc A Seelen, Felix Poppelaars

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · 2024

DOI: 10.1177/08968608231198984 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2024. Verfasst von Bernardo Faria und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, The Netherlands. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite several advantages compared to haemodialysis (HD), peritoneal dialysis (PD) remains an underused dialysis technique due to its high technique failure rate related to membrane fibrosis and peritonitis events. Previous work has suggested a harmful role for the complement system in these processes, highlighting the need for a more comprehensive examination in PD.

Methods

Plasma levels of C1q, mannose-binding lectin (MBL), Properdin, Factor D, C3d/C3-ratio and soluble membrane attack complex (sC5b-9) were determined in PD patients ( n = 55), HD patients ( n = 41), non-dialysis chronic kidney disease (CKD) patients ( n = 15) and healthy controls ( n = 14). Additionally, C1q, MBL, Properdin, Factor D and sC5b-9 levels were assessed in the peritoneal dialysis fluid (PDF). In a subgroup, interleukin-6, matrix metalloproteinase-2 (MMP-2), myeloperoxidase (MPO) and elastase were measured in the PDF.

Results

PD patients had significantly higher systemic levels of sC5b-9 compared to healthy controls, CKD and HD patients ( p < 0.001). Plasma levels of C1q and C3d/C3-ratios were significantly associated with systemic sC5b-9 levels ( p < 0.001). Locally, sC5b-9 was detected in the PDF of all PD patients, and levels were approximately 33% of those in matched plasma, but they did not correlate. In the PDF, only Properdin levels remained significantly associated with PDF sC5b-9 levels in multivariate analysis ( p < 0.001). Additionally, PDF levels of sC5b-9 positively correlated with elastase, MPO and MMP-2 levels in the PDF ( p < 0.01).

Conclusions

Our data reveal both systemic and local complement activation in PD patients. Furthermore, these two processes seem independent considering the involvement of different pathways and the lack of correlation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal DialysisRenal Insufficiency, ChronicHumansMatrix Metalloproteinase 2ProperdinComplement Factor DComplement C1qComplement ActivationDialysis SolutionsPancreatic Elastase

Stichwörter der Autor:innen

Chronic kidney diseasecomplementinnate immunityperitoneal dialysis

Substanzen

Matrix Metalloproteinase 2ProperdinComplement Factor DComplement C1qDialysis SolutionsPancreatic Elastase

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, The Netherlands.
  • Nephrology and Infectious Disease R&D Group, INEB, Institute of Investigation and Innovation in Health (i3S), University of Porto, Portugal.
  • Department of Medicine, Faculty of Medicine, University of Porto, Portugal.
  • Department of Anesthesiology, University Medical Center Groningen, University of Groningen, The Netherlands.
  • Division of Nephrology, Hospital São Teotônio, Viseu, Portugal.
  • Department of Nephrology, Leiden University Medical Center, University of Leiden, The Netherlands.

Zitieren

APA

Faria, B., Gaya da Costa, M., Meter-Arkema, A. H., Berger, S. P., Lima, C., Pêgo, C., van den Born, J., Franssen, C. F., Daha, M. R., Pestana, M., Seelen, M. A., & Poppelaars, F. (2024). Systemic and local complement activation in peritoneal dialysis patients via conceivably distinct pathways. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. https://doi.org/10.1177/08968608231198984

Vancouver

Faria B, Gaya da Costa M, Meter-Arkema AH, Berger SP, Lima C, Pêgo C, et al. Systemic and local complement activation in peritoneal dialysis patients via conceivably distinct pathways. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 2024. doi:10.1177/08968608231198984

BibTeX
@article{Faria2024,
  author = {Faria, Bernardo and Gaya da Costa, Mariana and Meter-Arkema, Anita H and Berger, Stefan P and Lima, Carla and Pêgo, Catia and van den Born, Jacob and Franssen, Casper Fm and Daha, Mohamed R and Pestana, Manuel and Seelen, Marc A and Poppelaars, Felix},
  title = {Systemic and local complement activation in peritoneal dialysis patients via conceivably distinct pathways},
  journal = {Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis},
  year = {2024},
  doi = {10.1177/08968608231198984}
}
Kostenlos starten →